amikacin has been researched along with Cognitive Dysfunction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azad, M; Gupta, S; Khandelwal, M; Manglani, K; Upadhyay, P | 1 |
| Liu, B; Liu, CL; Liu, J; Wang, JG; Yan, HJ | 1 |
| Bunting, M; Chan, KH; Chan, PK; Chu, LW; Chung, SK; Festenstein, R; Iyaswamy, A; Jian, M; Kumar Durairajan, SS; Kwan, JS; Lam, KS; Leung, KM; Li, M; Ma, OK; Ng, RC; Senthilkumar, K; Zhou, GJ | 1 |
3 other study(ies) available for amikacin and Cognitive Dysfunction
| Article | Year |
|---|---|
AdipoRon induces AMPK activation and ameliorates Alzheimer's like pathologies and associated cognitive impairment in APP/PS1 mice.
Topics: Adiponectin; Alzheimer Disease; AMP-Activated Protein Kinases; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cognitive Dysfunction; Disease Models, Animal; Insulin; Insulin Resistance; Mice; Mice, Transgenic; Plaque, Amyloid; Receptors, Adiponectin | 2022 |
AdipoRon improves cognitive dysfunction of Alzheimer's disease and rescues impaired neural stem cell proliferation through AdipoR1/AMPK pathway.
Topics: Alzheimer Disease; AMP-Activated Protein Kinases; Animals; Cell Proliferation; Cognition; Cognitive Dysfunction; Disease Models, Animal; Hippocampus; Mice; Mice, Transgenic; Neural Stem Cells; Piperidines; Receptors, Adiponectin; Signal Transduction | 2020 |
Chronic oral administration of adipoRon reverses cognitive impairments and ameliorates neuropathology in an Alzheimer's disease mouse model.
Topics: Administration, Oral; Aged; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cognitive Dysfunction; Disease Models, Animal; Humans; Mice; Mice, Transgenic; Piperidines | 2021 |